Tenaya Therapeutics (TNYA) Current Leases (2021 - 2026)

Tenaya Therapeutics has reported Current Leases for 6 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 11.49% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (up 11.49% YoY), and the FY2025 full-year result was $3.0 million, up 8.71% from the prior year.
• Current Leases for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
• The five-year high for Current Leases was $4.3 million in Q4 2023, with the low at $2.1 million in Q1 2022.
• Average Current Leases over 5 years is $3.3 million, with a median of $3.2 million recorded in 2023.
• Year-over-year, Current Leases soared 138.0% in 2022 and slumped 35.68% in 2024.
• Tracing TNYA's Current Leases over 5 years: stood at $4.0 million in 2022, then increased by 7.81% to $4.3 million in 2023, then sank by 35.68% to $2.8 million in 2024, then grew by 8.71% to $3.0 million in 2025, then grew by 3.15% to $3.1 million in 2026.
• The last three Current Leases figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.

Peer Comparison